// App-Quantinova.ai

755 : Management of Meningococcal Disease Risk in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) on Complement Inhibitors: 18 Years’ Experience from the UK National PNH Service in Leeds

Researchers

Presenter

  • Louise Arnold

Principal Investigators

  • Ray Borrow

  • Kathryn Riley

  • Talha Munir

  • Richard Kelly

  • Rachael Jones

  • Jeanifer Gachev

  • Briony Forrest

  • Alexandra Pike

  • Petra Muus

  • Peter Hillmen

  • Morag Griffin

Medical Centers

  • Meningococcal Reference Unit,, Manchester, United Kingdom

  • Department of Diabetes and Endocrinology, St James University Hospital, Leeds, United Kingdom

  • St. James's University Hospital, Leeds, United Kingdom

  • St. James University Hospital, Institute of Oncology, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Paroxysmal nocturnal hemoglobinuria

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved